Page last updated: 2024-11-07

prisma-fil

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

heliobond: visible-light-curing monomer component of composite resins [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID122022
SCHEMBL ID6779525
MeSH IDM0111979

Synonyms (13)

Synonym
heliobond
86159-08-2
helioseal
103469-50-7
prisma-fil
26426-05-1
SCHEMBL6779525
bis-gma tegma
SXMUXFDPJBTNRM-UHFFFAOYSA-N
bis-gma tegdma
DTXSID80908434
[(ethane-1,2-diyl)bis(oxy)ethane-2,1-diyl] bis(2-methylprop-2-enoate)--{(propane-2,2-diyl)bis[(4,1-phenylene)oxy]-2-hydroxypropane-3,1-diyl} bis(2-methylprop-2-enoate) (1/1)
[2-hydroxy-3-[4-[2-[4-[2-hydroxy-3-(2-methylprop-2-enoyloxy)propoxy]phenyl]propan-2-yl]phenoxy]propyl] 2-methylprop-2-enoate;2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethyl 2-methylprop-2-enoate

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Heliobond and Syntac were the least toxic materials."( In vitro cytotoxicity of six dentin bonding agents.
Dionysopoulos, P; Koliniotou-Koubia, E; Kortsaris, AH; Koulaouzidou, EA; Papadogiannis, Y, 2001
)
0.31
" CB was the least toxic sealer amongst the chemicals tested."( Cytotoxicity of dentine-bonding agents on human pulp cells in vitro.
Chang, YC; Huang, FM, 2002
)
0.31
" The tested adhesives were more toxic in the polymerized form than in the dilutions."( Cytotoxicity evaluation of three light-cured dentin adhesive materials on human gingival fibroblasts, ex vivo.
Bielawska, A; Kierklo, A; Pawińska, M; Popławska, B; Tokajuk, G, 2012
)
0.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (219)

TimeframeStudies, This Drug (%)All Drugs %
pre-199020 (9.13)18.7374
1990's62 (28.31)18.2507
2000's71 (32.42)29.6817
2010's66 (30.14)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 14.29

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index14.29 (24.57)
Research Supply Index5.73 (2.92)
Research Growth Index4.84 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (14.29)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials52 (20.39%)5.53%
Reviews1 (0.39%)6.00%
Case Studies7 (2.75%)4.05%
Observational0 (0.00%)0.25%
Other195 (76.47%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]